Deficiency of the mitochondrial transporter of aspartate/glutamate aralar/AGC1 causes hypomyelination and neuronal defects unrelated to myelin deficits in mouse brain
暂无分享,去创建一个
T. Saheki | J. Satrústegui | A. del Arco | M. Ramos | I. Llorente-Folch | B. Pardo | Irene Llorente‐Folch
[1] Miguel Garzón,et al. Brain Glutamine Synthesis Requires Neuronal-Born Aspartate as Amino Donor for Glial Glutamate Formation , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] D. Bok,et al. Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination , 2010, Neurobiology of Disease.
[3] D. Jacobowitz,et al. Nuclear‐cytoplasmic localization of acetyl coenzyme a synthetase‐1 in the rat brain , 2010, The Journal of comparative neurology.
[4] Daniela Calvetti,et al. Energetics of Inhibition: Insights with a Computational Model of the Human GABAergic Neuron–Astrocyte Cellular Complex , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] N. Pattabiraman,et al. Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: Implications for specialized acetyl coenzyme A metabolism in the CNS , 2010, Brain Research.
[6] J. Buxbaum,et al. Slc25a12 Disruption Alters Myelination and Neurofilaments: A Model for a Hypomyelination Syndrome and Childhood Neurodevelopmental Disorders , 2010, Biological Psychiatry.
[7] T. Saheki,et al. Low levels of citrin (SLC25A13) expression in adult mouse brain restricted to neuronal clusters , 2010, Journal of neuroscience research.
[8] Klaus-Armin Nave,et al. Myelination and the trophic support of long axons , 2010, Nature Reviews Neuroscience.
[9] F. Sterky,et al. AGC1 deficiency associated with global cerebral hypomyelination. , 2009, The New England journal of medicine.
[10] R. Matalon,et al. Lack of aspartoacylase activity disrupts survival and differentiation of neural progenitors and oligodendrocytes in a mouse model of Canavan disease , 2009, Journal of neuroscience research.
[11] A. Munnich,et al. Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts , 2009, Clinical genetics.
[12] D. Attwell,et al. The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes , 2009, Brain : a journal of neurology.
[13] B. Barres,et al. Nur7 Is a Nonsense Mutation in the Mouse Aspartoacylase Gene That Causes Spongy Degeneration of the CNS , 2008, The Journal of Neuroscience.
[14] K. Plate,et al. Wnt/β-catenin signaling controls development of the blood–brain barrier , 2008, The Journal of cell biology.
[15] Y. Xing,et al. A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.
[16] T. Saheki,et al. Role of aralar, the mitochondrial transporter of aspartate‐glutamate, in brain N‐acetylaspartate formation and Ca2+ signaling in neuronal mitochondria , 2007, Journal of neuroscience research.
[17] T. Nabeshima,et al. A Novel Molecule “Shati” Is Involved in Methamphetamine-Induced Hyperlocomotion, Sensitization, and Conditioned Place Preference , 2007, The Journal of Neuroscience.
[18] J. Moffett,et al. N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.
[19] T. Speed,et al. Functional Genomic Analysis of Oligodendrocyte Differentiation , 2006, The Journal of Neuroscience.
[20] H. Büssow,et al. Oligodendrocyte‐specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT‐deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level , 2005, Glia.
[21] T. Saheki,et al. Reduced N-Acetylaspartate Levels in Mice Lacking Aralar, a Brain- and Muscle-type Mitochondrial Aspartate-glutamate Carrier* , 2005, Journal of Biological Chemistry.
[22] Peter J. Brophy,et al. Mechanisms of axon ensheathment and myelin growth , 2005, Nature Reviews Neuroscience.
[23] J. Moffett,et al. Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Munnich,et al. Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. , 2005, American journal of human genetics.
[25] B. Popko,et al. Galactolipids are molecular determinants of myelin development and axo-glial organization. , 2002, Biochimica et biophysica acta.
[26] B. Trapp,et al. N‐acetylaspartate is an axon‐specific marker of mature white matter in vivo: A biochemical and immunohistochemical study on the rat optic nerve , 2002, Annals of neurology.
[27] R. Ledeen,et al. Intraneuronal N‐acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin‐associated aspartoacylase , 2001, Journal of neurochemistry.
[28] D. Rowitch,et al. Oligodendrocyte development in the spinal cord and telencephalon: common themes and new perspectives , 2001, International Journal of Developmental Neuroscience.
[29] V. Ganapathy,et al. Transport of N-acetylaspartate by the Na(+)-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain. , 2000, The Journal of pharmacology and experimental therapeutics.
[30] R Reynolds,et al. NG2‐expressing cells in the central nervous system: Are they oligodendroglial progenitors? , 2000, Journal of neuroscience research.
[31] T. Serikawa,et al. Accumulation of N‐Acetyl‐L‐Aspartate in the Brain of the Tremor Rat, a Mutant Exhibiting Absence‐Like Seizure and Spongiform Degeneration in the Central Nervous System , 2000, Journal of neurochemistry.
[32] B. Popko,et al. Effects of galactolipid elimination on oligodendrocyte development and myelination , 2000, Glia.
[33] J. Kamholz,et al. GFAP‐positive and myelin marker‐positive glia in normal and pathologic environments , 2000, Journal of neuroscience research.
[34] S. Bluml. In VivoQuantitation of Cerebral Metabolite Concentrations Using Natural Abundance13C MRS at 1.5 T , 1999 .
[35] B. Popko,et al. Demyelination and altered expression of myelin‐associated glycoprotein isoforms in the central nervous system of galactolipid‐deficient mice , 1998, Journal of neuroscience research.
[36] M. Berry,et al. The relationship between developing oligodendrocyte units and maturing axons during myelinogenesis in the anterior medullary velum of neonatal rats , 1997, Journal of neurocytology.
[37] A. Bosio,et al. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[38] A. Blight,et al. Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability , 1996, Cell.
[39] M. Namboodiri,et al. N-acetylaspartate as an acetyl source in the nervous system. , 1995, Brain research. Molecular brain research.
[40] D. Gadian,et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[41] M. Schachner,et al. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. , 1981, Developmental biology.
[42] K. McCarthy,et al. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue , 1980, The Journal of cell biology.
[43] K. Lanoue,et al. Electrogenic characteristics of the mitochondrial glutamate-aspartate antiporter. , 1974, The Journal of biological chemistry.
[44] P. Courtoy,et al. Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. , 2009, The Biochemical journal.
[45] Beatriz Pardo,et al. Mitochondrial transporters as novel targets for intracellular calcium signaling. , 2007, Physiological reviews.